(1R,9S,10S)-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol | 107989-08-2

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: (1R,9S,10S)-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,13-diol
• CAS: 107989-08-2
• 化学式: C₁₉H₂₇NO₄
• 分子量: 333.428
• InChiKey: PHUHOTJSRRFTRH-QCHKRLDQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
  申请人：Trawick Bobby N.

  公开号：US20110136845A1

  公开（公告）日：2011-06-09

  The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat pain. Also provided are pharmaceutical combination compositions comprising a (+)-morphinan and an opioid agonist/monoamine reuptake inhibitor, as well as methods for using the combination compositions to treat pain.
• (+)-MORPHINANS AS ANTAGONISTS OF TOLL-LIKE RECEPTOR 9 AND THERAPEUTIC USES THEREOF
  申请人：Mallinckrodt LLC

  公开号：US20150335638A1

  公开（公告）日：2015-11-26

  The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as methods for using the (+)-morphinans to treat a variety of disorders.
• US9562014B2
  申请人：——

  公开号：US9562014B2

  公开（公告）日：2017-02-07